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ABSTRACT 
 
A major function of the brain choroid plexus (CP) is to regulate the exchange of solutes 
between the blood plasma and the cerebrospinal fluid (CSF) using selective transporters. CSF 
inorganic phosphate (Pi) concentration is maintained at about one-half that of plasma and is 
potentially important because of its regulatory, structural, and biochemical functions. Phosphate 
is critical for ATP and DNA formation, the linked regulation between phosphate and calcium, 
and as an intracellular buffer. The human body has two major Pi transporter gene families known 
as SLC34 (NaPi-II) and SLC20 (PiT), which have wide tissue distribution. Although both 
families are secondary-active and sodium-dependent, they are distinguished by their transport 
mechanisms and functional properties. NaPi-II-type and PiT-type transporters are characterized 
by their substrate stoichiometry and inhibition profile. Unlike NaPi-II-type transporters, PiT-type 
transporters are not inhibited by phosphonoformic acid (PFA) and can partially substitute Li+ for 
Na+. Bataille et al. (unpublished) used these differences to characterize the effects of arsenate, 
PFA, and Li+ on CP phosphate transport. The results indicate that a PiT-type transporter is 
responsible for Pi transport in the CP. To further support this hypothesis, RT-PCR and western 
blotting were performed to definitively determine if NaPi-II-type transporters are present or 
absent from the CP. The results confirm the presence of PiT-like transporters but also indicate 
that NaPi-IIb is potentially present in the CP. Thus, the secondary-active, CP transport of 
phosphate out of the CSF may involve more than one family of solute carrier transporters. 
 
 
 
 
 
 
 
Le 5 
1. INTRODUCTION  
 
1.1 The Choroid Plexus and CSF Formation 
 
 Also known as the “kidney of the brain,” the choroid plexus (CP) tissues are 
interventricular organ that secrete two-thirds of total cerebrospinal fluid and mediate the 
transport of solutes between the blood plasma to the cerebrospinal fluid (CSF) (10, 32). The CP 
is divided into four parts with tissues in each lateral ventricle, third ventricle, and fourth 
ventricle, as seen in Figure 1(28). CP tissue is comprised of a continuous monolayer of cuboidal 
and columnar epithelial cells that is situated on connective tissue (Figure 2). The lateral 
ventricles of the mammalian brain have sheet-like choroid plexus structures, whereas the choroid 
plexuses in the third and four ventricles are branched villi that protrude into the ventricle (7). 
Each villus has a central vascular axis that is covered by ciliated cuboidal epithelium with 
numerous mitochondria. The epithelium also contains dendritic cells, which suggests that the CP 
may play in active role in immunological brain protection (28).  
The CP is paired with the fenestrated endothelium of the cerebral capillary beds to form 
the blood-CSF barrier (Figure 3) (10). The epithelium layer folds into numerous small villi to 
increase surface area and is designated as the major barrier of substrate movement between the 
blood and CSF (7). One of the CP’s major functions is to transport essential CSF electrolytes, 
such as Na+, Cl-, HCO3-, K+, and the topic of this report, inorganic phosphate (Pi), across its 
epithelium (32).  In addition to epithelial transport, the CP is responsible for the majority (two-
thirds) of total CSF production.  Extrachoroidal sites make up the latter third of total CSF 
production with less than 10% of total CSF formation coming from brain interstitial fluid and the 
rest originating from water produced in the brain cells by glucose oxidation and ultrafiltration 
across the cerebral microvessels (23). The rate of CSF production is relatively high compared to 
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total human CSF volume (150-170 mL), suggesting that CSF is constantly renewed and old fluid 
is removed by bulk flow. Over a 24 hour period, it has been estimated that ~600 mL of CSF is 
produced, a large enough volume to replace existing CSF three to four times (23). CSF 
production begins with passive filtration of fluid across choroidal capillary endothelium followed 
by active secretion across the CP (10). 
 The role of the CP in CSF production is important because the CSF physically and 
chemically protects the brain. The buoyancy of CSF reduces the weight of the brain nearly 30-
fold, from 1,500 grams to approximately 50 grams. This translates into a decreased pressure on 
blood vessels and nerves attached to the CNS. Moreover, the buoyant nature of CSF prevents the 
cerebrum from crushing the brainstem and serves as a mechanical buffer to protect the CNS from 
damage caused by physical impact to the skull (7, 23, 29). To maintain a stable environment 
within the intraventricular milieu, CSF is constantly secreted which then displaces older fluid. 
This is important because the brain lacks lymphatic capillaries, and CSF flow assists in the 
removal of waste products, debris, bacteria, and viruses (10, 29). CSF flow starts within the 
ventricle cavities, into the subarachnoid space, and finally drains into the systemic circulation via 
the dural sinuses (Figure 4) (7, 29). The fluid flows unidirectionally due to the presence of valve-
like mechanisms to prevent the regurgitation of blood into the subarachnoid space (6). 
  Because of the brain’s special metabolic requirements, the composition of CSF is vital to 
brain health. Neurons require a constant glucose and oxygen supply for ATP synthesis to fuel 
active transport of ions and neurotransmitters. Thus, the brain receives 15% of the blood pumped 
by the heart (29). To illustrate the importance of the choroid plexus, the blood flow to the CP is 
10 times higher than the blood flow to the brain parenchyma and five times higher than the blood 
flow to the kidney, on a per gram basis. The adult human CP secretes the equivalent of 10% of 
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the received blood flow or approximately 0.5 liters/day. Despite fluctuations in blood flow and 
pressure, the CP is remarkable at balancing CSF production and reabsorption to maintain an 
intracranial pressure between 5-15 mm Hg above that of the arterial blood. Moreover, the CP is 
extraordinary at keeping CSF composition constant over time despite changes in the blood 
compartment. For instance, CSF [K+] increases by less than 2 mM when plasma [K+] changes 
from 1.6 to 11 mM (7). The ability to finely control CSF formation has been a challenge but is 
clinically important due to its relation to brain fluid disorders such as congenital hydrocephaly. 
Congenital hydrocephalus is one of the most common birth defects, affecting up to 1 in 500 
births and is severe because it disrupts brain development, which ultimately decreases 
neurogenesis (13). Most attempts to regulate CSF formation are focused on altering ion 
movement via transporters in the membranes of CP epithelium (10). 
 
1.2 Phosphate in Physiological Systems 
 
Pi is an essential dietary nutrient that is absorbed from food as an electrically charged salt 
anion. In fact, phosphorus is the sixth most abundant element in the body (9). Approximately 
85% of Pi in the body is found in the bones, 14% is in the cells of soft tissues, and the remaining 
1% is in extracellular fluids (16). Extracellular [Pi] must be stable at ~1.1 mM for proper cellular 
function (18). The CSF has a Pi concentration held between 0.5 mM and 1.0 mM, whereas the 
plasma has a [Pi] range between 1.5 to 1.8 mM (2). The reason for the lower CSF [Pi] relative to 
plasma [Pi] is unexplained.  
Every cell requires Pi for structural, metabolic, and regulatory purposes.  Examples of 
cellular structures that incorporate phosphate are the DNA backbone, phospholipids in the cell 
membranes, and phosphoproteins that are necessary for mitochondrial function. Moreover, 
important intracellular compounds such as cyclic adenine and the enzymatic co-factor 
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nictoniamide diphosphate are dependent on intracellular phosphate pools for their formation 
(24).  
Another physiological function of phosphate is the regulation of intracellular processes, 
such as protein, fat, and carbohydrate metabolism. Phosphorylation is a major regulatory process 
that may directly modulate numerous enzymatic reactions, including glycolysis and 
ammoniagenesis. Pi seems to have its most obvious role as the source of the high-energy bonds 
in ATP. The energy stored in ATP provides the energy for vital physiological processes such as 
muscle contractility and electrolyte transport (29). Because of ATP’s various functions within 
the cell, Pi is an indicator of cellular metabolic capability.  
Pi is a triprotic acid and it loses its three hydrogen’s sequentially (29): 
 
1. H3PO4 (aq) H+(aq) + H2PO4-(aq) 
2. H2PO4- (aq) H+(aq) + HPO42-(aq) 
3. HPO42- (aq) H+(aq) + PO43-(aq) 
  
Physiological Pi is present in two forms H2PO4- and HPO42- and is a nearly ideal 
physiological buffer, as represented by equation 2 and evident by its 7.21 pKa (6). Eighty percent 
of plasma Pi is in the divalent form at physiological pH, which is slightly alkaline at 7.38-7.40 . 
H+ concentrations must be tightly regulated because dramatic changes in pH will disrupt the 
protein’s tertiary structure, leading to dysfunction. In the CNS, pH fluctuations may cause dire 
consequences. Acidosis can result in less excitable neurons and ultimately CNS depression. 
Patients exhibiting CNS depression are confused and disoriented and can potentially slip into a 
coma. If CNS depression continues, the respiratory centers fail, resulting in death. On the other 
hand, if the pH is too high, alkalosis causes neurons to become hyperexcitable, initiating action 
potentials at the slightest signal. At first, the condition clinically presents itself as sensory 
changes, such as numbness or tingling, and subsequently as muscle twitches (29). To prevent 
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these disorders, buffers are used as a first line of defense. The most common intracellular buffers 
are proteins and notably, Pi. Unlike plasma, CSF has an almost complete lack of protein (less 
than 0.5 g/L), yet the CSF pH is very stable. Changes in the concentration of plasma HCO3- have 
little effect on CSF [HCO3-]. However, an elevation in blood PCO2 results in an increase in CSF 
PCO2 but not as high as predicted. Thus, there must be some sort of mechanism that regulates pH, 
and Pi is a potential candidate to explain this phenomenon. Interestingly, a 0.05 unit drop in CSF 
pH causes a 10-fold increase in ventilation rate (7). 
 Varying Pi concentrations influence Ca2+ concentrations. Their regulation is linked which 
is further supported by the contribution of several organs and hormones that control both their 
concentrations. Intestinal absorption, bone (de)mineralization, and renal reabsorption/excretion 
are all affected by the same hormones that increase or decrease plasma [Ca2+] or [Pi]. For 
example, parathyroid hormone (PTH) increases plasma [Ca2+] by enhancing renal reabsorption 
and decreasing plasma [Pi] by increasing renal excretion. PTH also causes the mobilization of 
calcium from bones, resulting in a release of Pi (24). This is because 99% of Ca2+ and Pi are 
found in the bones in the form of hydroxyapatite, Ca10(PO4)6(OH)2 (19, 29). Although it is 
unknown whether hormones influence CP Pi transport, it is still pertinent to consider the effects 
of Pi on Ca2+ concentrations. 
 The relationship between Pi and Ca2+ concentrations is relevant because of the several 
physiological functions of calcium. Cells use calcium for intracellular signaling to initiate a 
variety of essential processes. For example, calcium initiates the exocytosis of synaptic and 
secretory vesicles and the contraction of muscle fibers. If plasma Ca2+ levels are not tightly 
controlled, neuron excitability can be induced.  Hypocalcemia increases neuronal permeability to 
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Na+, causing neuronal depolarization and CNS hyperexcitability. On the other hand, 
hypercalcemia, causes neuromuscular depression (29). 
 
1.3 Phosphate Transporters: SLC20 versus SLC34 
 
 Cells acquire Pi from extracellular fluid by secondary-active transport. Pi transporters 
drive Pi influx by utilizing the inwardly directed electrochemical Na+ gradient formed by Na+-
K+-ATPase. The two major Pi transporters are called NaPi-II (SLC34) and PiT (SLC20) and are 
similar in that they are both secondary active and Na+-coupled (33). However, the two solute 
protein carriers are distinguished by their mechanistic properties and physiological roles. 
 
SLC34 Transporter Family 
 
 The type II Na/Pi protein has three isoforms known as NaPi-IIa (SLC34A1), NaPi-IIb 
(SLC34A2), and NaPi-IIc (SLC34A3). Pi transporters from the SLC34 gene family are most 
highly expressed in the small intestine and in the renal proximal tubules, the two most important 
sites for controlling systemic Pi concentrations (18). The importance of the SLC34 transporter 
family is conveyed by the hyperphosphaturia, hypophosphatemia, and increased renal stone 
incidence documented in NaPi-IIa (Npt2a-/-) knockout mice and the presence of osteoporosis and 
nephrolithiasis in heterozygous mutated NaPi-IIa mice (Npt2a+/-) (20, 33).  
NaPi-II isoforms are differentially expressed throughout the body. Specifically, NaPi-IIa 
transporters have been found in bone and kidney, NaPi-IIb transporters are expressed in 
enterocytes and lung tissue, and NaPi-IIc transporters are exclusively seen in the kidney (18). All 
NaPi-II isoforms prefer the divalent Pi and are strictly dependent on Na+. An important 
difference between SLC20 and SLC34 is that the latter is inhibited by phosphonoformic acid 
(PFA), which makes NaPi-II identifiable during transport studies (33). 
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 NaPi-IIa-type transporters are an 80-90 kDa protein that is principally localized in the 
microvilli that make up the brush border membrane of the renal proximal tubule. NaPi-IIa 
transport cycles are electrogenic and characterized by an inward transfer of one net positive 
charge per cycle. Three Na+ ions and one HPO42- bind to the NaPi-II protein in a Na+/Pi/Na+ 
ordered manner, with substrate affinities of KmPi ~0.1 mM and KmNa ~70 mM. Transport rates are 
higher at more alkaline external pH values (18). Targeted type IIa knockout mice have 
demonstrated that NaPi co-transport in brush-border membrane vesicles is reduced by 70%, 
indicating that most proximal tubule Pi is by NaPi-IIa transporters (16). 
 NaPi-IIb mRNA expression has been identified in a variety of tissues that include the 
lung, small intestines, testis, mammary glands, and the liver. Immunofluorescence has indicated 
that NaPi-IIb-type transporters are localized to the brush borders of enterocytes and the apical 
membrane of alveolar type II cells. The fully glycosylated 108 kDa protein transports in an 
electrogenic, 3Na: 1Pi stoichiometric fashion and has a binding affinity of KmPi <50 µM and 
KmNa+ ~40 mM. There is moderate pH dependence, with a slightly higher co-transport at more 
acidic pH values (18). Although western blots have detected glycosylated proteins at 108 kDa, 
NaPi-IIb transporters have been observed to only be partially glycosylated in weaning animals 
(18). NaPi-IIb (Npt2b+/- and Npt2b-/-) knockout mice have been phenotypically analyzed and all 
Npt2b-/- mice died in utero, suggesting that NaPi-IIb-type transporters are essential for early 
embryonic development. In contrast, weaning hetero Npt2b+/- mice display hypophosphatemia 
and hypophosphaturia. Moreover, Ohi et al. showed that Npt2b+/- mice with adenine-induced 
renal failure had decreased plasma Pi levels compared with the level in Npt2b+/+ mice. These 
knockout studies demonstrate that NaPi-IIb is important as a therapeutic target for the prevention 
of hyperphosphatemia and is a regulator of systemic Pi homeostasis (19).  
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 The last SLC34 isoform, NaPi-IIc, is found exclusively on the apical membranes of the 
proximal tubules of the deep nephrons. In contrast to its counterparts, the 75 kDa protein is 
electroneutral with a transport Na:Pi stoichiometry of 2:1. Substrate affinity is KmPi 70 µM and 
KmNa 40 mM. NaPi-IIc is highly pH dependent and exhibits a higher transport at more alkaline 
pH (18, 27). Type IIc NaPi-knockout mice models have shown that it is responsible for residual 
Pi transport and accounts for 30% of renal Pi reabsorption (16). NaPi-IIc transporters are 
described as growth related. While the level of type IIa NaPi transporters increase with age, 
NaPi-IIc protein expression decreases with age and has its greatest expression in weaning 
animals. In the adult kidney, NapI-IIc transporters are localized to the midcortical region of the 
adult kidney but are found in the midcortical and superficical region in the kidney of weaning 
animals. In Npt2a-/- mouse kidneys, NaPi-IIc protein expression increased with age and persisted 
until adulthood [unpublished observation] (15). The high levels of the type-IIc isoform may 
compensate for reduced [Pi] transport when NaPi-IIa expression is low to support growth in 
Npt2a-/- mice. 
 
SLC20 Transporter Family 
 
Also described as retroviral receptors, the SLC20 solute carrier family preferentially 
transports Na+ and the monovalent H2PO4-. Two isoforms, PiT1(SLC20A1) and PiT2 
(SLC20A2)  make up the SLC20 family and share ~60% sequence homology (4, 33). The PiT 
proteins have wide tissue distribution but each isoform is differentially expressed. Unfortunately, 
there is only limited data on the distribution and subcellular localization of PiT1 and PiT2 
proteins. Some precise localization studies have shown that PiT expression in the distal 
convoluted tubule in the kidney and PiT2 mRNA has been found in epithelial cells along the 
crypt/villus axis in mouse small intestinal cells. Moreover, PiT1 mRNA has been detected in 
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osteoclasts and macrophages and transfected PiT1 proteins have localized to the basolateral 
membrane (33). Although the physiological role of SLC20 proteins has not been definitive, it has 
been suggested that PiT paralogs are cellular “housekeeping” proteins that maintain cellular Pi 
homeostasis. This is because SLC20 proteins are likely to have basolateral localization within 
epithelial cells and there is an upregulation of PiT protein expression when extracellular Pi levels 
are low (3, 4). 
 The PiT1 and PiT2 co-transporters specifically mediate the movement of Na+ and Pi 
across the cell membrane and have many distinguishing transport mechanisms. Both PiT proteins 
have a Na+:Pi transport stoichiometry of 2:1, and because the preferred substrate is H2PO4-, their 
transport is electrogenic. Unlike NaPi-II-type transporters, PiT proteins can substitute Na+ with 
Li+ to support Pi transport. Additionally, two studies have indicated that H+ can support Pi 
transport to a small extent in the absence of Na+. The optimal pH range for PiT1 and PiT2 Pi 
transport is between 6.2 and 8.0, and lowering the pH from 7.5 to 6.0 significantly increased Pi 
transport across the cell membrane. This is different from NaPi-II-mediated transport, which is 
strongly reduced at acidic pH because of the inhibitory effects of H+ and the decreased 
availability of HPO42-. Thus, PiT proteins are able to transport Pi at pH’s as acidic as 5.0 (3, 33).  
 Another distinguishing characteristic of PiT-mediated transport is the involvement of 
divalent ions. In the absence of Ca2+ and Mg2+, PiT1 and PiT2 Pi transport is impaired, yet 
sufficient. PiT1 and PiT2 transport was ~54% and ~58% of the transport in the absence of both 
divalent cations, respectively. Neither SLC20 protein is strictly dependent on Ca2+ and/or Mg2+, 
but studies have indicated that Mg2+ is dispensable as long as Ca2+ is present. Ca2+ involvement 
increased Pi transport the greatest, indicating that Ca2+ may have a regulatory function. PiT1 is 
the only SLC20 paralog that can substitute Mg2+, albeit only partially, in the absence of Ca2+. 
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PiT1 and PiT2 transporters are highly related, but there are a few differences. A notable 
functional difference is that PiT2 is the only isoform that can mediate Na+-independent Pi 
transport by translocating H+ (3). 
There are no known inhibitors of SLC20 family proteins. In contrast, NaPi-II proteins are 
inhibited by PFA. Although there are reports that PFA inhibits PiT proteins, the PFA 
concentration was high (>10 mM) and the membrane potential was not controlled, indicating that 
the inhibition might be nonspecific. Although there are no inhibitors of PiT2, arsenate does 
compete with Pi to reduce Pi transport in PiT proteins. These effects are similar in NaPi protein 
isoforms (33). 
 
SLC20 and SLC34 in a Physiological System 
The unrelated SLC20 and SLC34 families are unique because of their specificity for one 
of two phosphate species at physiological pH. Distinguishing characteristics of each family and 
its paralogs are displayed in Table 1. It is unclear whether these functional differences have any 
impact on the proteins’ physiological purposes. It should be noted that transporting either of the 
phosphate species will change the pH due to the equilibrium shift. The two solute carrier families 
differ in their optimum pH range but have an overlapping pH of 6.8. The PiT proteins have the 
greatest transport rate in the acidic range whereas the NaPi proteins favor transport in the 
alkaline range. Interestingly, the difference in substrate stoichiometry and preferred Pi species 
creates a 100-fold difference in Pi concentrative capacity. The difference in substrate 
stoichiometry may have physiological implications. NaPi-IIc transports one less Na+ ion and is 
electroneutral. Thus, NaPi-IIc-mediated transport has a smaller energetic cost because less Na+ is 
loaded into the cell and less energy is needed to keep the cell at a negative membrane potential 
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(33). PiT-type transporters could be favorable in the CNS because both PiT proteins respond to 
variations in extracellular Pi concentrations and a persistent deficiency will increase PiT1 and 
PiT2 mRNA. On the other hand, NaPi-II-type transporters are more sensitive to dietary Pi intake 
and hormonal factors. 
 
1.4 Phosphate Transport in Other Tissues 
 
 To better understand phosphate transport in the CP, it is useful to first consider phosphate 
transport in other tissues. The kidneys and the small intestines are two sites that are important in 
the maintenance of systemic Pi homeostasis and a brief review of phosphate balance in each 
organ is given below. 
 
Renal Phosphate Transport  
 
 The major site of Pi maintenance resides in the kidneys, primarily in the proximal 
tubules. The human kidneys are responsible for the reabsorption of 80% of the free phosphate 
ions that are filtered by the glomeruli with approximately 60% to 70% reabsorbed in the 
proximal tubules and 10 to 20% in the distal sites (17). The principle and rate-limiting step in Pi 
reabsorption is mediated by sodium-dependent Pi transporters that are in the brush border 
membrane. NaPi-II-type and PiT-type transporters are both present in the kidney, with the 
former as the central transporter (17, 18, 27) (Figure 5). The brush border membrane has both 
NaPi-IIa and NaPi-IIc isoform, and NaPi-IIa knockout mice have designated this isoform as the 
major player in systemic Pi homeostasis. This was supported by the 70% reduction in sodium-
dependent Pi cotransport in the apical membrane in NaPi-IIa knockout mice. The NaPi-IIc type 
KO mice model demonstrated that the type IIc transporter accounts for 30% of renal Na/Pi 
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mediated transport in the brush border membrane. PiT1 and PiT2 mRNA have been detected in 
proximal tubular cells but their protein localization has yet to be determined (17). Figure 5 is a 
schematic of the Pi transport in renal cells. 
 
Intestinal Phosphate Transport 
 
 The U.S Department of Agriculture’s Continuing Survey of Food Intakes by Individuals 
suggests a daily phosphorus intake in the range of 1,600 to 2,400 milligrams for males and 1,200 
to 1,600 milligrams for females. Fortunately, phosphorus is abundant in almost all food types 
and is ingested as Pi. Phosphates in the diet exist first as organic molecules that must be broken 
down by digestive enzymes to release Pi into intestinal fluids. The freed Pi is then ready for 
absorption by the intestine (9). 
 The primary site of Pi absorption is along the entire length of the small intestine, with 
some absorption at the colon when intestinal luminal Pi concentrations are extremely high. In 
vitro studies involving voltage clamp analysis or radiolabeled uptake have proven the existence 
of an active sodium-dependent Pi transport pathway in intestinal cells.. 
 The active transport of Pi is mediated by NaPi-II-type transporters and PiT-type 
transporters. Unlike the kidney, the small intestines employ the NaPi-IIb isoform for sodium-
dependent, inward transport of extracellular Pi. NaPi-IIb-type transporters have a relative high 
affinity for Pi (Km 10 µM), which suggests that NaPi-IIb can be saturated under most dietary 
conditions and is effective at transporting Pi even under conditions of dietary phosphate 
depletion. NaPi-IIb knockout studies have been performed in mice, and although decreased 
intestine phosphorus absorption has been reported in the KO mice, serum phosphorus and 
calcium concentrations were kept constant (25). This phenomenon may be explained by 
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compensatory mechanisms by the renal NaPi-IIa-type transporter and suggests that NaPi-IIb may 
be involved in the regulation of systemic Pi levels. 
Approximately 10% of the sodium-dependent Pi transport is not attributable to NaPi-IIb-
type transporters, resulting in the search for other Pi transporters in the small intestine. Although 
PiT proteins have been found in the basolateral membrane in a variety of tissues, evidence has 
demonstrated that PiT1 protein and PiT2 protein are actually expressed on the apical side of 
enterocyte epithelium. Literature has shown that NaPi-IIb-type and PiT-1-type transporters are 
primarily expressed in the duodenum and jejunum of rat small intestine (25). The role of PiT 
transporters in the small intestines has yet to be determined. 
 
1.5 Radiolabeled Phosphate Uptake Studies in Rat Z310 Choroid Plexus Epithelial Line 
 
The present study is based on the observations of radiolabeled phosphate uptake by  rat 
Z310 choroid plexus epithelial cells (Bataille et. al. (Unpublished)). The study showed that 
radiolabeled Pi uptake by Z310 cells increased as a function of time (Figure 6) and was not 
saturated at normal CSF Pi concentrations (0.9 mM) (Figure 7A). The Eadie-Hofstee plot (Figure 
7B) was generated by studying the transport of Pi by the Z310 cells at increasing external Pi 
concentration and indicated a Km=0.56 mM and Vmax= 7.68 nmoles/mg protein/5 minutes. 
Furthermore, Bataille et al. (unpublished) conducted studies which suggested that the primary Pi 
transporter is electrogenic and Na+ dependent, but can substitute Na+ with Li+ (Figure 8). This 
was evident by the inhibition of Pi uptake in the absence of sodium and by plasma membrane 
depolarization induced by high potassium Ringer and a diminished sodium gradient created by 
inhibiting Na+/K+/ATPase by 1 mM ouabain. Additionally, transporter inhibition studies were 
performed, and reduced Pi transport was observed in the presence of arsenate and antimycin A 
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when compared to the control. There was no change in transport when the Z310 cells were 
incubated with phosphonoformic acid (PFA) or methazolamide. (Figure 9).  
The uptake studies conducted by Bataille et al. (unpublished) described Pi uptake in Z310 
choroid plexus cells as sodium-dependent, able to partially substitute Na+ with Li+, electrogenic, 
and inhibited by arsenate but not PFA. Based on Table 1(33), the Pi uptake properties are 
consistent with those of PiT-like transporters. In addition, Bataille et. al. performed PiT2 
localization studies in Z310 CP cells (Figure 10) that show that PiT2 protein is present and 
appears to be localized to the plasma membrane. 
 
1.6 The Present Study 
 
 The cerebrospinal fluid provides the optimal environment for neurons to properly 
function. Interestingly, CSF Pi concentrations are one-half that of blood plasma. Thus, we 
questioned why the brain parenchyma prefers a lower Pi concentration than its plasma 
counterpart. We sought to determine the primary mechanism of Pi transport from the 
cerebrospinal fluid to plasma. Bataille, et al. (unpublished) conducted extensive radiolabeled 
uptake Pi in Z310 CP epithelial cells that suggest that the PiT family is the principle pathway for 
Pi to exit the CSF.  This was based on electrogenic and sodium-dependent Pi transport along with 
partial transport when Na+ was substituted with Li+ and inhibition by arsenate but not PFA.  
However, it remained to be determined whether NaPi-II-type transporters are present or absent in 
the CP. Therefore, the present study examined the presence of NaPi-II type family in CP 
secondary-active Pi transport in rat choroid plexus epithelial cells. To do this, semi-quantitative 
RT-PCR and western blotting studies were performed to determine if NaPi-II mRNA and protein 
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are expressed. Our results indicate that NaPi-IIb-type transporters may be in the rat choroid 
plexus, along with PiT1 and PiT2 transporters. 
 
2. MATERIALS AND METHODS 
 
2.1 Animal and Tissue Preparation 
  
 Intact rat choroid plexus, renal proximal tubule, gut, and lung tissues were from Sprague 
Dawley rats of mixed gender and varying ages and weight. Tissues were stored in RNAlater 
RNA stabilization reagent (Qiagen). The adult rat choroid plexus epithelium tissues in primary 
culture were from the lateral ventricle and were provided by Dr. Alice Villalobos.  All tissues 
were stored at -20°C and thawed on ice prior to use. 
 
2.2 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and PCR Product 
Visualization 
 
 RT-PCR analysis was conducted on adult and neonate rats for semi-quantitative mRNA 
analysis of NaPi-II-type and PiT-type transporters. Total RNA was extracted from adult and 
neonate rat choroid plexus cells, rat renal proximal tubule cells, rat gut cells, and rat lung cells 
using a Qiagen RNeasy mini kit. A Thermo Scientific Nanodrop was used to measure RNA 
concentrations. Twenty-five microliter RT-PCR master mixes were prepared using a Qiagen 
OneStep RT-PCR kit. 1 µg of total RNA of each sample was added to each master mix, which 
had a final reverse and forward primer concentration of 0.6 µM. The primers were designed 
against rat NaPi-IIa (SLC34A1, Accession # NM_013030.1, 630 BP), rat  NaPi-IIb (SLC34A2, 
Accession #NM_053380.2, 856 BP), rat NaPi-IIc (SLC34A3, NM_139338.1, Set 1 513 BP, Set 
4 786), rat PiT1 (SLC20A1, Accession # NM_031148.1, 758 BP) and rat PiT2 (SLC20A2, 
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Accession # NM_017223.2, 337 BP). Table 2 shows the nucleotide sequence, the nucleotide 
correspondence, and the amplified fragment size of each primer. 
RT-PCR was conducted in a PCR Sprint thermocycler (Thermo Electron Corporation). 
PCR amplification begins with an initial heating step at 50°C for thirty minutes and then 95°C 
for fifteen minutes to activate the HotStarTaq DNA polymerase. The cycle parameters are as 
follows: 94°C denaturing for 1 minute, 56°C annealing for 1 minute, and 72° extension for 1 
minute. The thermocycler was programmed for 32 cycles. Final extension was at 72°C for ten 
minutes and then held at 4°C until products were removed from the thermocycler. 
 PCR products were visualized on a 1% agrose gel with 0.1% of GelStar (nucleic acid 
stain). Fifteen microliters of the samples were loaded with 3 µL of 6X loading buffer (glycerol, 
0.5 M EDTA pH 8.0, 1% bromophenol blue). The gel was run at 70 V for approximately 3 
hours. A 1 KB plus DNA ladder (Invitrogen) was loaded and a UV detector was used to visualize 
the bands. 
 
2.3 Western Blotting 
  
 PiT1, PiT2, and NaPi-IIb protein expression was analyzed by western blotting. Intact rat 
choroid plexus cells were vigorously vortexed with 250 µL distilled H2O, 2.5 µL 1M KOH, and 
5 µL 2% protease inhibitor cocktail and then centrifuged at maximum speed for 1 minute. The 
supernatant was measured for protein concentration by Bio-Rad protein assay and then diluted 
2X with Kaman buffer. The samples were not boiled prior to electrophoresis. Proteins were 
separated by SDS-polyacrylamide gel electrophoresis at 120 V for 3 hours. The resolving and 
stacking gel was 10-12% and 4% acrylamide, respectively. Approximately 40 µg of each sample 
was loaded into each lane. A 5 µL full range rainbow MW marker (GE Healthcare) was also 
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loaded to measure protein size. Proteins were transferred to a polyvinylidene difluoride 
membrane using a transfer buffer (25 mM tris base, 192 mM glycine, 10% MeOH, 0.01% SDS, 
pH 8.3) and blocked with 3% PBS/tween/milk. The blot was probed with primary antibody in 
3% PBS/tween/milk (PiT1, PiT2, NaPi-IIb 1:500 dilution; β-actin 1:500 dilution). The 
membrane was incubated with PiT2, PiT1, and NaPi-IIb primary antibody overnight whereas β-
actin antibody was incubated with the membrane for 2 hours. Secondary antibody conjugated to 
horseradish peroxidase (HRP) was then added for approximately 1 hour. ECL western blotting 
reagent (Pierce) was used for band detection and exposed on ECL hyperfilm. 
Rabbit NaPi-IIb antibody (Accession # Q9DBP0) was from Abbiotec Company, San 
Diego, CA, rabbit anti-PiT1 (74 kDa) was obtained from Santa Cruz Biotechnology, Inc., and 
Dr. Victor Sorribas of the Universidad de Zaragoza provided us with the rabbit anti-PiT2. The 
secondary antibody was a goat anti-rabbit conjugated to horseradish peroxidase (Sigma Aldrich). 
The anti-β-actin was from Sigma-Aldrich. 
 
3. RESULTS 
 
3.1 Results of RT-PCR of Adult and Neonate Rat Choroid Plexus 
 
 RT-PCR was performed to determine the presence or absence of SLC34 and SLC20 
mRNA in adult and neonate rat choroid plexus cells. To ensure that the SLC34 and SLC20 
primers were properly functioning, negative and positive control RT-PCR analyses were 
conducted. Several sources have confirmed the presence of NaPi-IIa and NaPi-IIc but not NaPi-
IIb in the kidney (17, 18, 33). In contrast, the intact rat gut tissue has been reported to exclusively 
express the NaPi-IIb isoform (18, 25, 33). Figure 11A and 11B show the results of the RT-PCR 
of intact rat renal proximal tubule tissue and intact rat gut tissue. The RT-PCR confirmed the 
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presence of NaPi-IIa (~630 bp) and NaPi-IIc ((1) ~513 bp, (2) ~786 bp) in the rat renal proximal 
tubule; however, there was also a signal for NaPi-IIb (~856 bp). Since the proximal tubule tissue 
used in this analysis was intact, there was more than just nephron tissue in each sample. The 
extraneous tissue could be blood cells, endothelial cells or smooth muscle tissue that could 
account for the NaPi-IIb mRNA signal. The RT-PCR of the rat gut cells showed a signal for the 
NaPi-IIb isoform but not for NaPi-IIa and NaPi-IIc mRNA. This is consistent with the literature 
and further confirms the functionality of the primers. 
After testing the integrity of the primers, RT-PCR analysis was conducted on intact rat 
choroid plexus tissues to determine the presence of any NaPi-II isoform. The results are 
displayed in Figure 13 with rat kidney used as the control. There were no bands detected for any 
of the NaPi-II isoforms in rat CP but strong signals for NaPi-IIa (~630 bp) and NaPi-IIc (~786) 
and a weak signal for NaPi-IIb in the kidney tissue (~856 bp). 
 Additionally, a RT-PCR was performed on intact adult rat CP using PiT1 (~758 bp), PiT2 
(~337 bp), and NaPi-IIb (~856 bp) primers. The results are shown in Figure 12A. There was no 
PiT1 mRNA detection but there was a strong signal for PiT2 and a weaker signal for NaPi-IIb. A 
repeat of the preceding analysis was performed, but we used isolated choroid plexus epithelium 
in primary culture of adult and neonate rats as our samples. Figure 12B shows the results of the 
RT-PCR, which show a signal for both PiT1 and PiT2, albeit PiT2 had a stronger signal. No 
NaPi-IIb mRNA was detected in adult and neonate rat samples. Thus, it is not definitive whether 
NaPi-IIb mRNA is present in rat choroid plexus epithelium.  
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3.2 Results of Primary Rat Choroid Plexus Western Blot 
 
 The results from the RT-PCR have excluded the presence of NaPi-IIa and NaPi-IIc 
mRNA in the rat CP but confirmed the presence of PiT2 mRNA in the CP. The RT-PCR data on 
PiT1 and NaPi-IIb mRNA was inconclusive and a western blot was performed to determine 
protein expression. A western blot was also done to confirm PiT2 protein expression. Intact 
human choroid plexus tissues were analyzed alongside intact rat CP. The results are revealed in 
Figures 14 (PiT1 Expression), Figure 15 (PiT2 Expression), and Figure 16 (NaPi-IIb 
Expression). PiT1 expression was established in the rat and human CP by the presence of a band 
at ~74 kDa. Additionally, the immunoblot revealed the presence of PiT2 protein in rat and 
human CP by a band at ~72 kDa. The PiT2 western blot also showed bands present at ~76 kDa, 
and ~140 kDa that can be explained by glycosylation and dimerization, respectively (26, 33). 
The NaPi-IIb immunoblot indicated that NaPi-IIb proteins are expressed in the human and rat CP 
by the presence of a ~108 kDa band. Rat lung, which has been confirmed to only have NaPi-IIb-
type transporters, was used as a positive control (8). Each immunoblot also included assay of β-
actin (~42 kDa) to ensure equal protein loading between each sample. In the rat lung sample, the 
β-actin sample showed three bands. This is because of cell apoptosis which results in cleavage 
products. The initial cleavage results in a band at 41 kDa that appears as a doublet and further 
cleavage gives a major band at 30 kDa. The cleavage products could be a result of the actions of 
interleukin 1β-converting enzyme (1, 11). 
 
 
 
 
 
 
 
Le 24 
4. DISCUSSION 
 
 This study attempted to address how Pi is actively transported out of the CSF. The 
Bataille et al. radiolabeled Pi  uptake studies suggested that Pi transport has PiT-like 
characteristics. However, it has not been determined whether NaPi-II-type transporters play a 
role in mediating Pi transport. Figure 12A and Figure 12B display the results of an RT-PCR of rat 
CP and suggest the presence of PiT1, PiT2, and NaPi-IIb mRNA in the CP. The RT-PCR in 
Figure 12A showed that neonate and adult rat CP have PiT1 and PiT2 mRNA, with a stronger 
signal for PiT2 mRNA. Another sample of adult rat CP was also analyzed by RT-PCR with the 
same three primers and was revealed to have NaPi-IIb mRNA and PiT2 mRNA expression. 
Although PiT2 was found in all three samples, PiT1 and NaPi-IIb mRNA expression in the rat 
CP samples were inconsistent. This may be explained by the difference in sample preparation in 
Figure 12A and Figure 12B. In Figure 12A, the rat CP samples were isolated rat choroid plexus 
epithelium in primary culture whereas the samples in Figure 12B were intact rat choroid plexus 
tissue. The intact rat choroid plexus tissue has more than just CP epithelium. The choroid 
plexuses are leaf-like structures with rich capillary beds that are attached to the ependyma by a 
thin stalk. Additionally, the CP is lined with the ependyma to form its outer covering (23). 
Therefore, intact rat CP could include endothelial cells, smooth muscle, blood cells, and 
ependymal tissue that may have NaPi-IIb-type transporters.  
 In addition, Lau et al. reported PiT1- and PiT2-type transporters expression in rat 
vascular smooth muscle cells, with PiT1-type transporters more abundant than PiT2-type 
transporters. No NaPi-II isoform expression was seen (12, 30). Moreover, Di Marco et al. studied 
hyperphosphatemia, phosphate transport, and endothelial cell apoptosis. The investigators found 
PiT1 mRNA in endothelial cells but have not ruled out the presence of other Pi transporters. The 
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investigators also found that PFA prevented phosphate-induced apoptosis, suggesting that NaPi-
II transporters may be present in endothelial cells (14). Thus, tissue contamination could account 
for the PiT1 and NaPi-IIb signal. 
 This type of contamination can be seen in our control samples. In Figures 11 and Figure 
13, the rat kidney was used as a control to ensure the specificity of NaPi-II primers.  According 
to Murer, et al, renal proximal tubules only contain NaPi-IIa- and NaPi-IIc-type transporters, 
which was confirmed in the RT-PCR; however, we detected a signal for NaPi-IIb, which has 
been reported to be absent from the nephron (18). The intact rat kidney tissue included not just 
proximal tubule but endothelial cells, blood cells, and smooth muscle cells. Thus, this may be an 
example of contamination that could cause a false-positive for NaPi-IIb and explain the NaPi-IIb 
signal in the rat CP samples. 
 In addition to RT-PCR analysis, western blot analysis of PiT1, PiT2, and NaPi-IIb was 
performed to determine protein expression. The immunoblots indicated that intact rat CP have 
PiT1, PiT2, and NaPi-IIb proteins. Moreover, intact human CP samples were analyzed for 
protein expression and suggest the presence of PiT1, PiT2, and NaPi-IIb transporters. Because 
intact CP tissues were used, samples contained other tissues besides CP epithelium tissues that 
could account for the band in the immunoblot. 
 The contamination of CP with non-target tissues   has been problematic in our study. 
Although it is likely that PiT2-type transporters are the principle transporter in the CP, we cannot 
rule out PiT1 and NaPi-IIb. Thus, we must do immunohistochemistry studies to determine the 
localization of these transporters. 
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Pi Cellular Homeostasis and CP Function 
 
 Although the results suggest that NaPi-IIb could possibly play a role in CP Pi transport, 
PiT2-type transporters seem to have a definite role in Pi transport out of the CSF. This has been 
suggested by the PiT-like Pi uptake, PiT2 mRNA and protein expression, and the apparent PiT2 
localization in the plasma membrane of Z310 CP cells. These observations raise the question of 
why choroid plexus cells have PiT-type transporters instead of NaPi-II-type transporters. NaPi-II 
transporters are primarily expressed in the kidney and the gut, which reflects the SLC34 family’s 
principle role as the regulator of systemic Pi homeostasis. In contrast, because PiT-like 
transporters have wide tissue distribution, it has been suggested that they function as a regulator 
of cellular Pi homeostasis. PiT-1-like and PiT-2-like transporters have been found in all 
investigated human tissues, although at different levels. Moreover, PiT mRNA is regulated by 
various factors that include epinephrine, platelet-derived growth factor (PDGF), insulin-like 
growth factor (IGF-1), and most importantly, Pi concentrations (33). Reports have shown that 
persistent Pi starvation increases PiT1 and PiT2 mRNA. Interestingly, the [Pi] regulation of PiT-
2 transporters results in the formation of PiT-2 dimers, suggesting that PiT2 proteins play a role 
in phosphate sensing. Phosphate uptake is 4.5 and 2.5 times more efficient in phosphate deprived 
conditions than at 10 mM. In addition, PiT2 activity changes within minutes of Pi concentration 
variations. The adaption to Pi concentrations occurs without any significant modification to the 
number of PiT2 proteins, but rather a change in PiT2 structure, as seen in Figure 17. Salaün et al. 
reported that PiT2 assemblies, particularly those at the cell surface, may switch between two 
conformations. The proportion of individual PiT2 molecules that can be cross-linked is high in 
low extracellular Pi concentrations but is low in high extracellular Pi concentrations. Moreover, 
human PiT2 has positive cooperativity characteristics that are reflected by the dimerization of 
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human PiT2 in Pi starved environments (26). The ability of PiT-type transporters to finely sense 
extracellular Pi concentrations and quickly adapt to extracellular Pi concentrations is favorable 
for maintaining the CSF environment. 
 The Pi sensitivity of PiT-type transporters is essential if the primary function of the brain 
choroid plexus is taken into account. The ability to mediate the transport of solutes and produce 
cerebrospinal fluid is an energetically expensive process. Thus, the choroid plexus contains a 
high volume of mitochondria to support CSF secretion and maintain ionic gradients. In fact, 
Cornford, et al. reported a high mitochondrial volume (>13% of cytoplasmic volume) in 
mammalian choroid plexus cells that exceeds any previously reported brain cell (5). Pi plays a 
major role as a structural component of ATP and its uptake into the CP is essential for its 
function. If PiT-transporters are responsible for cellular Pi homeostasis, then its sensitivity to Pi 
is more optimal for providing enough ATP for CP function. 
 
CSF pH and PiT-Type Transporters 
 
 One of the most interesting, unexplained phenomenons of the CNS is the ability of the 
CSF to maintain a constant pH in the absence of protein. Because of the lack of protein, it seems 
likely that the CSF contains a large buffer concentration, particularly Pi, a dominant 
physiological buffer.  However, CSF Pi concentrations are held between 0.5 and 1.0 mM, about 
one-half the Pi concentration of the plasma (2). This low CSF Pi concentration is unexplained but 
may still play a role in the maintenance of CSF pH. A major difference between the SLC20 and 
SLC34 transporter gene families is their optimal pH range and preferred Pi substrate. The PiT 
proteins favor transport in the acidic range, and because PiT-type transporters favor H2PO4-, PiT-
mediated Pi transport would alkalinize the CSF. However, the most notable characteristic of PiT2 
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transporter is the ability to co-transport Pi with H+, unlike the NaPi-II-type transporters. Thus, 
PiT-mediated transport may be optimal because it can operate at low pH and at the same time 
alkalize the CSF. In fact, PiT2 is the only sodium-dependent Pi transporter that can undergo Na+-
independent-Pi transport by translocating H+. 
 
Central Control of Phosphate Appetite in Rats and Role of PiT-Type Transporters 
The lack of any essential nutrient in the diet has physiological implications. For example, 
zinc, magnesium, and potassium deficiency disrupt body growth and affect food intake variation.  
A disturbance in Pi homeostasis has serious repercussions, including bone abnormalities, stunted 
growth, and metabolic disorders.  Typically, mineral deficiencies cause an increase in Na+ 
ingestion; however, this is not the case with Pi, suggesting that Pi appetite is specific to Pi 
concentrations. Several groups have reported that dietary Pi has a direct effect on Pi craving. In 
2007, Ohnishi et al. performed a study that investigated whether a lowered Pi concentration in 
plasma and CSF will induce a Pi appetite in rats. The results showed that rats that were under a 
low Pi diet consumed 70%-100% more Pi than normal Pi diet rats. Moreover, low Pi diet rats had 
a significant reduction in Pi concentrations in the CSF and plasma (20). These results 
demonstrate that Pi appetite can be induced in rats and suggest that its action is through lowered 
plasma and CSF Pi concentrations. 
The Ohnishi et al. study indicates that there is some central control that regulates Pi 
concentrations.  However, it is unknown how the body manages to sense low Pi concentrations. 
The PiT-type family could potentially explain this phenomenon if it is present in the apical 
membrane of choroid plexus cells. As seen in Figure 17, PiT-type transporters adapt a 
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conformation that reflects the presence of a low or high Pi concentration and could potentially act 
as the Pi sensor in CSF (26). 
 
PiT2-Type Transporters, Calcium, and Inhibitors 
 
 The SLC20 family of transporters is also distinguished by the modulatory effects of 
divalent ions. PiT1- and PiT2-type transporters exhibited impaired, albeit sufficient, Pi transport 
in the absence of Ca2+ and Mg2+. Of the two divalent ions, Ca2+ increased Pi transport more 
significantly, suggesting that Ca2+ may regulate PiT function (3). The role of Ca2+ in CP Pi 
transport is noteworthy because of the concerted homeostasis of calcium and phosphate. As 
previously discussed, hypocalcemia increases neuronal permeability to Na+ which can result in 
CNS hyperexcitability whereas hypercalcemia can cause CNS depression. Thus, the unique 
ability of PiT-type transporters to be modulated by Ca2+ could be beneficial to maintaining an 
optimal milieu for the CNS. 
 The last major advantage of the PiT family is its lack of reported inhibitors, unlike the 
NaPi-II family, which is reported to be inhibited by PFA (33). This is a major benefit that 
ensures that the CP and CSF obtain sufficient amounts of Pi. 
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5. CONCLUSIONS 
 The present study focused on Pi transport out of the CSF and into CP cells. Although 
more studies need to be performed to determine the mechanism of CP Pi transport, it is likely 
that PiT2-type transporters play the largest role in mediating Pi out of the CSF, with a smaller 
contribution from PiT1-type transporters. Although Bataille et al. reported PiT-like Pi uptake, 
NaPi-IIb-type transporters may contribute to CP Pi transport. Figure 18 is a proposed model for 
CP Pi transport. The apical membrane may have PiT1, PiT2, and/or NaPi-IIb but all transport is 
electrogenic, bringing in a net positive charge. PiT-mediated transport introduces a positive 
charge, along with a build-up of H2PO4- and Na+. To prevent the accumulation of H2PO4- and a 
positive potential, there must be a transporter at the basolateral membrane that pushes H2PO4- out 
of the CP cell. The removal of H2PO4- alkalizes the cell while also removing a net negative 
charge.  A potential basolateral transporter that is capable of balancing the removal of H2PO4 is 
the Cl-/HCO3- exchanger, AE2. This transporter has been reported to be localized exclusively to 
the basolateral membrane of the mammalian CP and is known as a Cl- loader and base extruder 
(7). Thus, the acidic H2PO4 is pushed out of the CP with the basic HCO3-. Moreover, a sodium 
gradient must be sustained to continue to the uptake of Pi. 
 More work needs to be performed to perfect the CP Pi transport model. However, the 
significance of this study is that we now know that NaPi-IIa and NaPi-IIc transporters are not 
present in the choroid plexus. Determining the mode of CP Pi transport is important because 
physiological impact of Pi. Future work in CP Pi may help us clinically by explaining such 
phenomena as CSF formation or acid-base balance that when deregulated cause such pathologies 
as congenital hydrocephalus or CNS acidosis. 
 
Le 31 
6. AKNOWLEDGEMENTS 
 I would like to extend many thanks to Dr. Larry Renfro, my research, university scholar, 
and honors advisor, who supported and guided me throughout this whole project. Many thanks 
are also extended to Dr. Amy Bataille for her collaboration on this project and Sonda Parker, 
whose technical skills and support made this experience possible. Moreover, I would like to 
thank Dr. Joseph Crivello and Dr. Amy Howell, who were both on my University Scholar 
committee, and the University of Connecticut University Scholar and Honors Program. Finally, 
thank you to Dr. Victor Sorribas for providing us with the PiT2 antibody and Dr. Villalobos for 
providing us with primary rat choroid plexus epithelium. 
 This manuscript was supported by the National Science Foundation. 
 
 
 
 
 
 
 
Le 32 
 
FIGURE 1. Cartoon Representation of Adult Human Brain Ventricles by Lowry et. al.  
Blue is brain tissue, yellow is the brain ventricles, and red is the choroid plexuses. The blue 
arrows show the direction of CSF flow. LV= Lateral Ventricle, 3V= Third Ventricle, 4V=Fourth 
Ventricle 
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FIGURE 2.Schematic Representation and Differential Interference Contrast Micrograms 
of Mouse Choroid Plexus by Damkier et. al.  (A) Schematic representation of the brain and its 
ventricular system. Choroid Plexus is in orange, cerebrospinal fluid is in light blue, brain 
parenchyma is in gray, meninges in dark blue, and skull in green. III V. is the third ventricle and 
IV V is the fourth ventricle. (B) Differential interference contrast micrograph of the mouse 
fourth ventricle and choroid plexus at low magnification. (C) Higher magnification of a single 
villus of the same choroid plexus. 
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FIGURE 3. Morphology of Blood-CSF Interface by Johanson et. al.  The choroid plexus is a 
monolayer of cicumferentially arranged epithelial cells with a fenestrated capillar at its center 
and contains numberous mitochondria. The CP capillaries, unlike other brain caplicaries, are 
permeable to macromolecules. 
 
  
Choroid Plexus Epithelium 
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FIGURE 4. A Schematic Section through the Brain and Spinal Cord Showing the Drainage 
Pathways for CSF. CSF is formed by the choroid plexuses of the lateral ventricle (CPLV) and 
passes by the two foramina of Munro (FM) into the third ventricle (CPV3), where more CSF is 
produced by the CP. CSF then flows through the aqueduct of Sylvius (AS) and into the fourth 
ventricle. The CSF exits into the various basal cisterns (CI, CS) and then into the subarachnoid 
space (SAS) through the paired foramina of Luschka (FL) and single foramen of Magendie 
(FM). CSF flows through the subarachnoid space over the surface of the cortex. Some fluid 
drains into the blood via the arachnoid granulation (AG) into the superior sagittal sinus (SSS). 
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FIGURE 5. Localizations and Substrates of Sodium-Dependent Pi-Type Transporters in 
the Kidney. The brush border membrane has NaPi-IIa (Red), NaPi-IIc (Green), and PiT2 (Blue) 
transporters, whereas the basolateral membrane has Na+-K+-ATPase (Purple) and an unknown 
transporter (Orange) that mediates the movement of Pi back into the blood plasma. 
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FIGURE 6. Summary Data-Pi Uptake in Z310 Rat CP Epithelial Cell Line as a Function of 
Time.  Pi uptake was determined by the amount of radiolabeled Pi inside the cells at different 
time intervals. The amount of Pi inside the cell was normalized by the protein concentration of 
each sample. The figure demonstrates that uptake is linear at t= 5 minutes and is used as time 
frame for the other uptake experiments. 
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FIGURE 7. (A) Summary data of the Pi uptake in Z310 rat CP epithelial cell line at different 
external Pi concentrations. Uptake was determined by the amount of radiolabeled Pi inside the 
cells at t= 5 minutes and was normalized by the protein concentration of each sample. The results 
show that Pi uptake is not saturated at physiological Pi concentration (0.9 mM). (B) A Eadie-
Hostee plot was created from the summary data and revealed that Pi uptake has a Km of 0.56 mM 
and Vmax of 7.68 nmoles/mg protein/5 minutes. 
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1.6 The Present Study 
 
Hypothesis 
Observations 
 
2. MATERIALS AND METHODS 
 
2.1 Materials 
 
 
FIGURE 8. Summary Data of Pi Uptake in Z310 Rat CP Epithelial Cell Line in the 
Presence and Absence of Several Ions and Gradients. CP cells were pre-incubated in their 
respective treatments for 30 minutes before radiolabeled Pi was added at t=0 minutes. Uptake 
was then determined by measuring the amount of radiolabeled Pi inside the cells at t=5 minutes 
and normalizing the amount by the protein concentration of each sample. (A) Pi uptake is 
inhibited when NaCl is removed from the medium (sodium-free ringers). However, uptake was 
partially restored when 120 mM LiCl (lithium ringers) was added. (B) Pi uptake is inhibited by 
plasma membrane depolarization that was induced by high potassium Ringer (100 mM KCl) and 
by a diminished sodium gradient. The diminished sodium gradient was created by inhibiting the 
Na+/K+/ATPase by 1 mM ouabain. 
*Significantly different from the control or sodium ringers 
** Significantly different from sodium-free ringers 
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FIGURE 9. Summary Data of Pi Uptake in Z310 Rat CP Cell Line in the Presence of 
Various Known Phosphate Transporter Inhibitors Cells were pre-incubated in their 
respective inhibitor treatments for 30 minutes before radiolabeled Pi was added at t=0 minutes. Pi 
uptake was determined by the amount of radiolabeled Pi inside the cells at t= 5 minutes and was 
normalized by the protein concentration of each sample. Arsenate (10 mM) and antimycin A (0.1 
mM) inhibited Pi uptake when compared to controls. There was no change in Pi uptake when the 
cells were incubated with 1 mM PFA or 0.1 mM methazolamide. 
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FIGURE 10. Fluorescence Immunohistochemistry Analysis of PiT2 Protein Expression in 
the Z310 Choroid Plexus Epithelial Cell Line.  PiT2 staining was done with a commercially 
available anti-PiT2 (Sigma Aldrich) and a fluorescently tagged secondary antibody (green). 
Controls were labeled with secondary antibody only. The nuclei were visualized with Hoesct 
stain (blue). 
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FIGURE 11. Semi-Quantitative RT-PCR Products of mRNA Extracted from Rat Kidney 
and Rat Gut.  Primers were designed against the rat mRNA sequences for NaPi-IIa (SLC34A1, 
accession # NM_013030.1, 630 bp), NaPi-IIb (SLC34A2, accession #NM_053380.2, 856 bp), 
and NaPi-IIc (SLC34A3, accession # NM_139338.1 , (1) 513 bp, (2) 786 bp).  (A) RT-PCR was 
conducted in the kidney where NaPi-IIa and NaPi-IIc are known to occur. (B) The gut has been 
reported to have NaPi-IIb-type transporters. Thus, RT-PCR analysis was performed in the rat gut 
as positive and negative controls for the NaPi-II isoforms. 
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FIGURE 12. Semi-Quantitative RT-PCR Products of mRNA Extracted from Rat CP.  
(A) Total mRNA was extracted from adult and neonate rat choroid plexus epithelium in primary 
cultures, compliments of Dr. Alice Villalobos. The adult rat choroid plexus was from the IV 
ventricle. NaPi-IIb (SLC34A2, accession #NM_053380.2, 856 bp), PiT1 (SLC20A1, accession # 
NM_031148.1, 758 bp), and PiT2 (SLC20A2, accession # NM_017223.2, 337 bp) mRNA 
primers were used. (B) Primers were designed against NaPi-IIb, PiT1, and PiT2 mRNA and used 
in RT-PCR analysis in adult rat choroid plexus. 
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FIGURE 13. Semi-Quantitative RT-PCR Products of mRNA Extracted from Rat Choroid 
Plexus and Rat Kidney.  All three NaPi-II isoform primers were used in RT-PCR analysis of rat 
kidney and rat CP. Rat kidney was used as a positive control for NaPi-IIa and NaPi-IIc but acted 
as a negative control for NaPi-IIb. (NaPi-IIa: 630 bp, NaPi-IIb: 856 bp, NaPi-IIc: 786 bp) 
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FIGURE 14. Western Blot Analysis of PiT1 Transporter Expression in Intact Rat and 
Human CP tissue. Rat and human choroid plexus cell proteins were separated by SDS-PAGE 
electrophoresis and transferred to a PVDF membrane. The membranes were probed with primary 
rabbit anti-PiT1 (Santa Cruz Biotechnology) and rabbit anti-β and stained with the secondary 
antibody, goat anti-rabbit HRP-conjugated IgG. Bands were visualized by ECL luminescence. 
PiT1 (74 kDa), β-Actin (~42 kDa) 
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FIGURE 15.  
 
 
 
 
FIGURE 15. Western Blot Analysis of PiT2 Expression in Rat and Human Choroid Plexus 
Cells. 40 µg samples of rat and human choroid plexus cells were loaded and separated by 12% 
SDS-PAGE gel electrophoresis. Immunoblots were stained with either PiT2 (From Sorribas, et. 
al., ~72 kDa) or β-actin primary antibody (~42 kDa) and then secondary antibody (goat anti-
rabbit Hrp-conjugated IgG). Bands were detected by ECL luminescence. 
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FIGURE 16. Western Blot Analysis of NaPi-IIb Expression in Rat and Human Choroid 
Plexus Cells. Approximately 40 µg of intact rat and human choroid plexus cells were separated 
by electrophoresis on a 10% SDS-polyacrylamide gel and then transferred to a PVDF membrane. 
The top gel was incubated overnight with primary rat anti-NaPi-IIb (Abbiotec Biotechnology, 
~108 kDa), whereas the bottom gel was incubated with rabbit anti-β-actin (~42 kDa) for two 
hours. ECL luminescence was used to visualize bands. Rat lung tissue was used as a positive 
control.  
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FIGURE 17. Schematic Representation of the Configuration of Cell Surface PiT2 
Assemblies at Various [Pi] by Salaün et al.  At low [Pi], PiT2 assemblies are in a “compact” 
configuration, which allows cross-linking of monomers. This configuration mediates active Pi 
uptake. (2, 3) At higher [Pi], PiT2 assemblies are in a relaxed configuration. The distance 
between the monomers allows efficient cross-linking and is associated with inactive Pi uptake. 
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FIGURE 18. Proposed Model of Pi Transport in Choroid Plexus Cells. Green= PiT2, Red= 
Na+-K+-ATPase, Purple= Unknown Basolateral Pi Transporter, Blue= AE2 
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Table 1. Properties of Sodium-Dependent Phosphate Transporters by Virkki et. al. 
(2007)(Virkki et al., 2007) 
 
Na+/Pi Cotransporters Substrates Stoichiometry Na+/Pi Electrogenic PFA Block 
NaPi-IIa Na+, HPO42-, Arsenate 3:1 Yes Yes 
NaPi-IIb Na+, HPO42-, Arsenate 3:1 Yes Yes 
NaPi-IIc Na+, HPO42-, Arsenate 2:1 No Yes 
PiT-1 Na+, H2PO4-, Li+, Arsenate 2:1 Yes No 
PiT-2 Na+, H2PO4-, Li+, Arsenate 2:1 Yes No 
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TABLE 2. Nucleotide Sequence, Nucleotide Correspondence and Fragment Size of Primers 
used in RT-PCR Amplification. 
 
Primer Name Nucleotide Sequence Nucleotide 
Correspondence 
Amplified 
Fragment Size 
SLC34A1_For 5’-TCC AGC ACC TCG ACA TCC ATC ATT-3’ 540 630 
SLC34A1_Rev 5’-TGA GCA CAG CGT ATG ACT ATG GCA-3’ 1146 630 
SLC34A2_For 5’-TGA GCA CAG CGT ATG ACT ATG GCA-3’ 2202 856 
SLC34A2_Rev 5’-TGA GCA CAG CGT ATG ACT ATG GCA-3’ 3035 856 
SLC34A3_For (1) 5’-TGA GAA ATG CAG GGA CCT CTG GTT-3’ 162 513 
SLC34A3_Rev (1) 5- AAG GCC CTC TGA AAT TCA TCC CGA-3’ 651 513 
SLC34A3_For (2) 5’-AAG GCA CTG ACT CGA CCT TTC ACA-3’ 803 786 
SLC34A3_Rev (2) 5’-AGA CAA TGG CTA CCC AGC GGT ATT-3’ 1565 786 
SLC20A1_For 5’- CAA ACA TTG GCC TTC CCA TCA GCA-3’ 1898 758 
SLC20A1_Rev 5’- TGC CAA AGA TTC TCG GCC CTC TAA-3’ 2633 758 
SLC20A2_For 5’-TGC AGT GGA TGG AAC TCG TCA AGA-3’ 818 337 
SLC20A2_Rev 5’-TCT TCA TCC ACG GAC ACA CGA ACA-3’ 1132 337 
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